Which has preferable valuation & earnings, AVAH or TALK?

Aveanna Healthcare has higher revenue and earnings than Talkspace. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aveanna Healthcare $2.43B 1.19 $225.03M $1.23 10.83 Talkspace $228.87M 3.84 $7.79M N/A N/A

Which has higher earnings and valuation, TALK or PRVA?

Privia Health Group has higher revenue and earnings than Talkspace. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Talkspace $228.87M 3.84 $7.79M N/A N/A Privia Health Group $2.12B 1.25 $22.92M $0.21 99.00

Which has preferable valuation and earnings, TALK or WGS?

Talkspace has higher earnings, but lower revenue than GeneDx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Talkspace $228.87M 3.84 $7.79M N/A N/A GeneDx $454.43M 5.67 -$21.02M -$3.64 N/A

Is TALK or WGS more profitable?

Talkspace has a net margin of 0.08% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat Talkspace's return on equity. Company Net Margins Return on Equity Return on Assets Talkspace 0.08% 0.17% 0.14% GeneDx -23.41% 4.12% 2.26%

Which has preferable earnings and valuation, ADUS or TALK?

Addus HomeCare has higher revenue and earnings than Talkspace. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.52 $95.91M $5.70 20.27 Talkspace $228.87M 3.84 $7.79M N/A N/A

Which has preferable valuation & earnings, ASTH or TALK?

Astrana Health has higher revenue and earnings than Talkspace. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.67 $22.49M $0.82 46.29 Talkspace $228.87M 3.84 $7.79M N/A N/A

Talkspace (TALK) Competitors

$5.25 0.00 (0.00%)

As of 08/17/2026

Compare

TALK vs. AVAH, PRVA, WGS, ADUS, and ASTH

Should you buy Talkspace stock or one of its competitors? Talkspace's main competitors and comparable companies include Aveanna Healthcare (AVAH), Privia Health Group (PRVA), GeneDx (WGS), Addus HomeCare (ADUS), and Astrana Health (ASTH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Talkspace compare to Aveanna Healthcare?

Aveanna Healthcare (NASDAQ:AVAH) and Talkspace (NASDAQ:TALK) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

Aveanna Healthcare presently has a consensus target price of $13.50, suggesting a potential upside of 1.35%. Talkspace has a consensus target price of $5.56, suggesting a potential upside of 5.95%. Given Talkspace's higher probable upside, analysts clearly believe Talkspace is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 57.4% of Talkspace shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Comparatively, 23.5% of Talkspace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aveanna Healthcare had 40 more articles in the media than Talkspace. MarketBeat recorded 41 mentions for Aveanna Healthcare and 1 mentions for Talkspace. Talkspace's average media sentiment score of 1.38 beat Aveanna Healthcare's score of 0.49 indicating that Talkspace is being referred to more favorably in the news media.

Company	Overall Sentiment
Aveanna Healthcare	Neutral
Talkspace	Positive

Aveanna Healthcare has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market. Comparatively, Talkspace has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

Aveanna Healthcare has higher revenue and earnings than Talkspace.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.19	$225.03M	$1.23	10.83
Talkspace	$228.87M	3.84	$7.79M	N/A	N/A

Aveanna Healthcare has a net margin of 10.56% compared to Talkspace's net margin of 0.08%. Aveanna Healthcare's return on equity of 80.70% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Talkspace	0.08%	0.17%	0.14%

Summary

Aveanna Healthcare beats Talkspace on 11 of the 15 factors compared between the two stocks.

How does Talkspace compare to Privia Health Group?

Talkspace (NASDAQ:TALK) and Privia Health Group (NASDAQ:PRVA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

Privia Health Group has a net margin of 1.19% compared to Talkspace's net margin of 0.08%. Privia Health Group's return on equity of 3.52% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talkspace	0.08%	0.17%	0.14%
Privia Health Group	1.19%	3.52%	2.00%

57.4% of Talkspace shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Privia Health Group has higher revenue and earnings than Talkspace.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talkspace	$228.87M	3.84	$7.79M	N/A	N/A
Privia Health Group	$2.12B	1.25	$22.92M	$0.21	99.00

In the previous week, Privia Health Group had 10 more articles in the media than Talkspace. MarketBeat recorded 11 mentions for Privia Health Group and 1 mentions for Talkspace. Privia Health Group's average media sentiment score of 1.59 beat Talkspace's score of 1.38 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Talkspace	Positive
Privia Health Group	Very Positive

Talkspace currently has a consensus target price of $5.56, indicating a potential upside of 5.95%. Privia Health Group has a consensus target price of $31.00, indicating a potential upside of 49.11%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Talkspace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Talkspace has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Summary

Privia Health Group beats Talkspace on 11 of the 14 factors compared between the two stocks.

How does Talkspace compare to GeneDx?

Talkspace (NASDAQ:TALK) and GeneDx (NASDAQ:WGS) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

57.4% of Talkspace shares are owned by institutional investors. Comparatively, 61.7% of GeneDx shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 25.2% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Talkspace presently has a consensus price target of $5.56, suggesting a potential upside of 5.95%. GeneDx has a consensus price target of $89.57, suggesting a potential upside of 3.75%. Given Talkspace's higher probable upside, equities research analysts plainly believe Talkspace is more favorable than GeneDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
GeneDx	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89

Talkspace has a net margin of 0.08% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talkspace	0.08%	0.17%	0.14%
GeneDx	-23.41%	4.12%	2.26%

Talkspace has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, GeneDx has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market.

In the previous week, GeneDx had 6 more articles in the media than Talkspace. MarketBeat recorded 7 mentions for GeneDx and 1 mentions for Talkspace. Talkspace's average media sentiment score of 1.38 beat GeneDx's score of 1.26 indicating that Talkspace is being referred to more favorably in the media.

Company	Overall Sentiment
Talkspace	Positive
GeneDx	Positive

Talkspace has higher earnings, but lower revenue than GeneDx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talkspace	$228.87M	3.84	$7.79M	N/A	N/A
GeneDx	$454.43M	5.67	-$21.02M	-$3.64	N/A

Summary

GeneDx beats Talkspace on 11 of the 15 factors compared between the two stocks.

How does Talkspace compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Talkspace (NASDAQ:TALK) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Addus HomeCare had 14 more articles in the media than Talkspace. MarketBeat recorded 15 mentions for Addus HomeCare and 1 mentions for Talkspace. Talkspace's average media sentiment score of 1.38 beat Addus HomeCare's score of 1.33 indicating that Talkspace is being referred to more favorably in the news media.

Company	Overall Sentiment
Addus HomeCare	Positive
Talkspace	Positive

Addus HomeCare has higher revenue and earnings than Talkspace.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.52	$95.91M	$5.70	20.27
Talkspace	$228.87M	3.84	$7.79M	N/A	N/A

Addus HomeCare currently has a consensus price target of $130.88, suggesting a potential upside of 13.26%. Talkspace has a consensus price target of $5.56, suggesting a potential upside of 5.95%. Given Addus HomeCare's stronger consensus rating and higher probable upside, equities analysts clearly believe Addus HomeCare is more favorable than Talkspace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Talkspace has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 57.4% of Talkspace shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 23.5% of Talkspace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Addus HomeCare has a net margin of 7.13% compared to Talkspace's net margin of 0.08%. Addus HomeCare's return on equity of 9.96% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Talkspace	0.08%	0.17%	0.14%

Summary

Addus HomeCare beats Talkspace on 11 of the 15 factors compared between the two stocks.

How does Talkspace compare to Astrana Health?

Astrana Health (NASDAQ:ASTH) and Talkspace (NASDAQ:TALK) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Astrana Health has a net margin of 1.05% compared to Talkspace's net margin of 0.08%. Astrana Health's return on equity of 10.30% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.05%	10.30%	3.67%
Talkspace	0.08%	0.17%	0.14%

Astrana Health has higher revenue and earnings than Talkspace.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.29
Talkspace	$228.87M	3.84	$7.79M	N/A	N/A

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 23.5% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Astrana Health had 1 more articles in the media than Talkspace. MarketBeat recorded 2 mentions for Astrana Health and 1 mentions for Talkspace. Talkspace's average media sentiment score of 1.38 beat Astrana Health's score of 0.94 indicating that Talkspace is being referred to more favorably in the news media.

Company	Overall Sentiment
Astrana Health	Positive
Talkspace	Positive

Astrana Health has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Talkspace has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

Astrana Health presently has a consensus target price of $49.43, suggesting a potential upside of 30.21%. Talkspace has a consensus target price of $5.56, suggesting a potential upside of 5.95%. Given Astrana Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Astrana Health is more favorable than Talkspace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Astrana Health beats Talkspace on 9 of the 14 factors compared between the two stocks.

Get Talkspace News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TALK vs. The Competition

Export

Metric	Talkspace	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$879.43M	$9.83B	$7.18B	$12.89B
Dividend Yield	N/A	2.56%	2.54%	11.28%
P/E Ratio	N/A	34.42	273.17	25.45
Price / Sales	3.84	5.01	637.71	104.31
Price / Cash	81.52	24.48	28.74	36.03
Price / Book	7.39	5.30	11.08	6.36
Net Income	$7.79M	$310.63M	$3.48B	$349.79M
7 Day Performance	N/A	-0.48%	0.38%	-0.40%
1 Month Performance	0.57%	1.18%	7.89%	4.24%
1 Year Performance	97.37%	15.34%	24.71%	15.13%

Talkspace Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TALK Talkspace	2.089 of 5 stars	$5.25 flat	$5.56 +6.0%	N/A	$879.43M	$228.87M	N/A	500	Positive News
AVAH Aveanna Healthcare	3.5393 of 5 stars	$13.70 +4.1%	$12.89 -5.9%	+66.5%	$2.87B	$2.43B	11.14	35,500	Analyst Forecast Gap Up
PRVA Privia Health Group	4.4437 of 5 stars	$21.02 -0.5%	$31.00 +47.5%	-9.8%	$2.70B	$2.12B	100.10	1,226	Positive News
WGS GeneDx	2.4997 of 5 stars	$85.19 -2.2%	$89.57 +5.1%	-33.3%	$2.60B	$454.43M	N/A	1,300	Positive News Gap Up
ADUS Addus HomeCare	4.0987 of 5 stars	$120.82 +0.0%	$130.88 +8.3%	+0.3%	$2.26B	$1.42B	21.20	50,659	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TALK) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Talkspace (TALK) Competitors

TALK vs. AVAH, PRVA, WGS, ADUS, and ASTH

How does Talkspace compare to Aveanna Healthcare?

Summary

How does Talkspace compare to Privia Health Group?

Summary

How does Talkspace compare to GeneDx?

Summary

How does Talkspace compare to Addus HomeCare?

Summary

How does Talkspace compare to Astrana Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TALK vs. The Competition

Talkspace Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Talkspace (TALK) Competitors

TALK vs. AVAH, PRVA, WGS, ADUS, and ASTH

How does Talkspace compare to Aveanna Healthcare?

Do analysts prefer AVAH or TALK?

Do insiders & institutionals have more ownership in AVAH or TALK?

Does the media prefer AVAH or TALK?

Which has more volatility and risk, AVAH or TALK?

Which has preferable valuation & earnings, AVAH or TALK?

Is AVAH or TALK more profitable?

Summary

How does Talkspace compare to Privia Health Group?

Is TALK or PRVA more profitable?

Do institutionals & insiders believe in TALK or PRVA?

Which has higher earnings and valuation, TALK or PRVA?

Does the media refer more to TALK or PRVA?

Do analysts rate TALK or PRVA?

Which has more risk & volatility, TALK or PRVA?

Summary

How does Talkspace compare to GeneDx?

Do institutionals & insiders have more ownership in TALK or WGS?

Do analysts prefer TALK or WGS?

Is TALK or WGS more profitable?

Which has more volatility and risk, TALK or WGS?

Does the media favor TALK or WGS?

Which has preferable valuation and earnings, TALK or WGS?

Summary

How does Talkspace compare to Addus HomeCare?

Does the media refer more to ADUS or TALK?

Which has preferable earnings and valuation, ADUS or TALK?

Do analysts prefer ADUS or TALK?

Which has more risk and volatility, ADUS or TALK?

Do insiders and institutionals hold more shares of ADUS or TALK?

Is ADUS or TALK more profitable?

Summary

How does Talkspace compare to Astrana Health?

Is ASTH or TALK more profitable?

Which has preferable valuation & earnings, ASTH or TALK?

Do insiders & institutionals have more ownership in ASTH or TALK?

Does the media refer more to ASTH or TALK?

Which has more volatility & risk, ASTH or TALK?

Do analysts recommend ASTH or TALK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TALK vs. The Competition

Talkspace Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools